Public health authorities continue to stress that early detection among high risk groups is an essential component of disease management and improved patient outcomes in HIV (human immunodeficiency virus) and hepatitis C. This multi-state initiative evaluates the impact of providing community access to screening for at-risk patients. For patients with reactive tests, immediate linkage to care occurs through collaboration with local public health entities. The U.S. Centers for Disease Control and Prevention (CDC) is providing public health expertise and insight into study design and implementation.
Study location: Michigan, West Virginia, Ohio, Georgia
Research Team: CDC, University of Nebraska Medical Center, Ferris State University